Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclosporine is angiostatic.

K Norrby1

  • 1Department of Pathology, University of Göteborg, Sweden.

Experientia
|December 1, 1992
PubMed
Summary

Cyclosporine (CS), an immunosuppressive drug, was found to selectively inhibit new blood vessel formation (angiogenesis) in rats. This finding suggests potential new uses for CS in treating diseases driven by excessive blood vessel growth.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mast cells and de novo angiogenesis: Angiogenic capability of individual mast-cell mediators such as histamine, TNF, IL-8 and bFGF.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2016
Same author

In vivo models of angiogenesis.

Journal of cellular and molecular medicine·2006
Same author

Intratumoral microvascular density in malignant lymphomas of B-cell origin.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2001
Same author

Constitutively synthesized nitric oxide is a physiological negative regulator of mammalian angiogenesis mediated by basic fibroblast growth factor.

International journal of experimental pathology·2001
Same author

Oral administration of a nitric oxide synthase inhibitor enhances de novo mammalian angiogenesis mediated by TNF-alpha, saline and mast-cell secretion.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2001
Same author

Orally administered bovine lactoferrin systemically inhibits VEGF(165)-mediated angiogenesis in the rat.

International journal of cancer·2001

Area of Science:

  • Immunopharmacology
  • Vascular Biology
  • Regenerative Medicine

Background:

  • Angiogenesis, the formation of new blood vessels, is crucial for physiological processes but also implicated in diseases.
  • The immunosuppressive drug cyclosporine (CS) is widely used in organ transplantation and autoimmune conditions.
  • Understanding the systemic effects of CS on angiogenesis is important for its clinical application.

Purpose of the Study:

  • To quantitatively assess the systemic effect of cyclosporine on angiogenesis in a rat model.
  • To determine if CS exhibits angiostatic properties and to characterize its mechanism of action.
  • To explore potential clinical implications of CS's effect on blood vessel formation.

Main Methods:

  • Utilized the rat mesenteric-window assay for quantitative angiogenesis assessment.
  • Administered cyclosporine subcutaneously at a clinically relevant dose (4 mg/kg/day).
  • Induced angiogenesis via intraperitoneal saline injection.

Main Results:

  • Cyclosporine significantly suppressed angiogenesis in the mesenteric-window assay.
  • CS primarily inhibited the branching and tortuosity of new vessels, rather than their spatial expansion.
  • The observed angiostatic effect of CS was achieved at a non-toxic dose, suggesting selectivity.
  • This study presents the first report of a selective angiostatic effect of cyclosporine.

Conclusions:

  • Cyclosporine demonstrates a selective inhibitory effect on angiogenesis.
  • The findings suggest potential therapeutic applications for CS beyond immunosuppression, particularly in angiogenesis-dependent diseases.
  • Further research into CS's angiostatic properties may refine its use in organ transplantation and offer new treatment avenues for conditions like psoriasis.

Related Experiment Videos